发明名称 |
SUBCUTANEOUS THERAPEUTIC USE OF DPP-4 INHIBITOR. |
摘要 |
<p>The present invention relates to methods for treating and/or preventing metabolic diseases comprising the subcutaneous or transdermal administration of a therapeutically effective amount of a certain DPP-4 inhibitor. The invention further relates to a subcutaneous combination of a certain DPP-4 inhibitor and GLP-1 having a short half life, particularly for reducing weight.</p> |
申请公布号 |
MX2014007768(A) |
申请公布日期 |
2014.09.22 |
申请号 |
MX20140007768 |
申请日期 |
2012.12.28 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
MICHAEL MARK;THOMAS KLEIN |
分类号 |
A61K31/00;A61K31/522;A61K38/26;A61P3/00;A61P3/10 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|